US · Healthcare

Cullinan Oncology LLC (CGEM)

Biotechnology

Cullinan Oncology LLC (CGEM) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CGEM

P/E ratio

25.00

Cullinan Oncology LLC (CGEM) — FAQ

What is CGEM's P/E ratio?

The price-to-earnings (P/E) ratio for Cullinan Oncology LLC (CGEM) is 25.00 (data as of 2026-05-23).

Does Cullinan Oncology LLC pay a dividend?

Dividend yield is not available in the current snapshot for Cullinan Oncology LLC (CGEM). Check the MyAverix Finance app for the latest dividend data.

What sector is Cullinan Oncology LLC in?

Cullinan Oncology LLC (CGEM) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CGEM listed on?

CGEM is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)